These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15862436)

  • 1. Is there an optimal hematocrit value for cardiac patients?
    Cheng TO
    J Am Coll Cardiol; 2005 May; 45(9):1549; author reply 1550-1. PubMed ID: 15862436
    [No Abstract]   [Full Text] [Related]  

  • 2. Further aspects of anemia, heart failure, and erythropoietin.
    Kovacic JC
    J Am Coll Cardiol; 2005 May; 45(9):1549-50; author reply 1550-1. PubMed ID: 15862435
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of anaemia in chronic heart failure--optimal approach still unclear.
    Murphy NF; McDonald K
    Eur Heart J; 2007 Sep; 28(18):2185-7. PubMed ID: 17704094
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism.
    Trunzo JA; McHenry CR; Schulak JA; Wilhelm SM
    Surgery; 2008 Dec; 144(6):915-8; discussion 919. PubMed ID: 19040997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin and heart failure: the end of a promise?
    Kleijn L; Westenbrink BD; van der Meer P
    Eur J Heart Fail; 2013 May; 15(5):479-81. PubMed ID: 23558218
    [No Abstract]   [Full Text] [Related]  

  • 6. Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure.
    Zilberman M; Silverberg DS; Bits I; Steinbruch S; Wexler D; Sheps D; Schwartz D; Oksenberg A
    Am Heart J; 2007 Nov; 154(5):870-6. PubMed ID: 17967592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heart failure: erythropoietin in treatment of anemia].
    Büyüklü M
    Anadolu Kardiyol Derg; 2007 Sep; 7(3):342-3. PubMed ID: 17785241
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA black box for EPO: what should nephrologists do?
    Singh AK
    Nephrol News Issues; 2007 May; 21(6):55-6, 58-9. PubMed ID: 17518125
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythropoietin stimulating agents and epoetin alfa revisited: what's really relevant?
    Walker RG
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):935-7. PubMed ID: 18579671
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?
    Slotki I
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii16-23. PubMed ID: 16024827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodilution is a mechanism of anaemia in patients with heart failure: reply.
    Westenbrink BD; Kleijn L; van der Meer P
    Eur J Heart Fail; 2013 Sep; 15(9):1075-6. PubMed ID: 23960086
    [No Abstract]   [Full Text] [Related]  

  • 13. Anemia in heart failure: marker or mediator of adverse prognosis?
    Levy WC
    J Am Coll Cardiol; 2008 Feb; 51(5):577-8. PubMed ID: 18237688
    [No Abstract]   [Full Text] [Related]  

  • 14. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoiesis-stimulating agents in heart failure: no proof of effectiveness or proof of no effectiveness?
    Messori A; Fadda V; Maratea D; Trippoli S
    Eur J Heart Fail; 2013 Aug; 15(8):944-5. PubMed ID: 23884182
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anemia as complication of chronic heart failure: prevalence, treatment, prognosis].
    Tereshchenko SN; Atroshchenko ES; Uskach TM; Kudinova AA; Riabinina MN
    Ter Arkh; 2008; 80(9):90-5. PubMed ID: 19555048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Erythropoietin in patients with chronic heart failure].
    Makarova NA; Shaposhnik II; Zakharov IuM
    Klin Med (Mosk); 2009; 87(3):31-4. PubMed ID: 19469252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemodilution is a mechanism of anaemia in patients with heart failure.
    Prakash ES
    Eur J Heart Fail; 2013 Sep; 15(9):1074. PubMed ID: 23883650
    [No Abstract]   [Full Text] [Related]  

  • 19. The FDA, stocks, black boxes and ESAs.
    Spry L
    Nephrol News Issues; 2007 May; 21(6):53-4. PubMed ID: 17518124
    [No Abstract]   [Full Text] [Related]  

  • 20. Reaction from renal associations. Renal Physicians Association.
    Blaser R
    Nephrol News Issues; 2007 May; 21(6):61-2, 64. PubMed ID: 17518126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.